Biota Scientific Management Pty Ltd

Taxis Pharmaceuticals, Inc.

Biota Europe Limited

Jeffrey Peter Mitchell

Alistair George Draffan

Penelope Anne Mayes

Kelly Helen Anderson

Silas Bond

Gary Robert William Pitt

Laura Andrau

Gary Pitt

Vanessa Anne Sanford

Chin Yu Lim

Lloyd George Czaplewski

David John Haydon

Ian Collins

James T Palmer

John Nicholas Lambert

David Davies

Edward Malcolm Tyndall

Roland Henry Nearn

Daniel Offermann

Neil Robert Stokes

Colin William Gordon Fishwick

Andrew Ian Yule

Chin Lim Lim

Ian Andrew Yule

The present invention relates to polycyclic antiviral compounds, and salts thereof, methods for their preparation and compositions containing them, and the use of the compounds and composition in the treatment of viral infections.

Polycyclic agents for the treatment of respiratory syncytial virus infections

The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections

The present invention provides compounds of Formula (I): and salts, racemates, isomers, diastereoisomers, enantiomers, hydrates, solvates, N-oxides, pharmaceutically acceptable derivatives or prodrugs thereof. Also provided the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture. 

Aromatic amides and uses thereof

Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections

The present invention provides a compound of the following formula, racemates, enantiomers and salts thereof. Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture. 

Heterocyclic urea compounds

The present invention relates to compounds of formula (I), racemates, isomers and/or salts thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds. 

Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections

[object Object]

Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl etc., (B&#x2014;C) may be CH&#x2014;CHetc., (R) may be phenyl and substituted forms thereof, (R) may be assorted substituents. 

Growing community of inventors

Notting Hill, Australia

Jeffrey Peter Mitchell